| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.78 | 0.003 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 4e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-10 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |